RCEP a “grave threat to access to medicines,” says MSF
March 4, 2017: As RCEP negotiations continue in Japan, Doctors Without Borders (MSF) has sent a letter to all negotiating countries to express their serious concern over provisions that threaten to restrict access to medicines for millions of people by delaying access to cheaper medicines and by allowing pharmaceutical companies to sue governments in international tribunals.
MSF writes that proposed provisions in the leaked draft investment chapter could undermine access to medicines by allowing pharmaceutical companies to claim millions of dollars in compensation from governments if they regulate access to medicines. Pharmaceutical companies have sued or threaten to sue governments in Canada, Colombia and the Ukraine because they have tried to make medicines more affordable.
Read the full letter here.
Share MSF’s campaign via Facebook here.
Sending a message to Australian Trade Minister Steve Ciobo here.